QQQ   416.58 (-1.61%)
AAPL   165.21 (-1.10%)
MSFT   400.47 (-0.94%)
META   482.95 (-3.76%)
GOOGL   153.94 (-1.33%)
AMZN   174.91 (-2.40%)
TSLA   147.99 (-1.29%)
NVDA   787.22 (-7.03%)
AMD   147.62 (-4.81%)
NIO   3.83 (-4.25%)
BABA   68.99 (+0.16%)
T   16.47 (+0.86%)
F   12.11 (+0.41%)
MU   107.10 (-4.32%)
GE   148.90 (-2.64%)
CGC   8.05 (+2.81%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.12 (+0.03%)
XOM   120.00 (+1.25%)
QQQ   416.58 (-1.61%)
AAPL   165.21 (-1.10%)
MSFT   400.47 (-0.94%)
META   482.95 (-3.76%)
GOOGL   153.94 (-1.33%)
AMZN   174.91 (-2.40%)
TSLA   147.99 (-1.29%)
NVDA   787.22 (-7.03%)
AMD   147.62 (-4.81%)
NIO   3.83 (-4.25%)
BABA   68.99 (+0.16%)
T   16.47 (+0.86%)
F   12.11 (+0.41%)
MU   107.10 (-4.32%)
GE   148.90 (-2.64%)
CGC   8.05 (+2.81%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.12 (+0.03%)
XOM   120.00 (+1.25%)
QQQ   416.58 (-1.61%)
AAPL   165.21 (-1.10%)
MSFT   400.47 (-0.94%)
META   482.95 (-3.76%)
GOOGL   153.94 (-1.33%)
AMZN   174.91 (-2.40%)
TSLA   147.99 (-1.29%)
NVDA   787.22 (-7.03%)
AMD   147.62 (-4.81%)
NIO   3.83 (-4.25%)
BABA   68.99 (+0.16%)
T   16.47 (+0.86%)
F   12.11 (+0.41%)
MU   107.10 (-4.32%)
GE   148.90 (-2.64%)
CGC   8.05 (+2.81%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.12 (+0.03%)
XOM   120.00 (+1.25%)
QQQ   416.58 (-1.61%)
AAPL   165.21 (-1.10%)
MSFT   400.47 (-0.94%)
META   482.95 (-3.76%)
GOOGL   153.94 (-1.33%)
AMZN   174.91 (-2.40%)
TSLA   147.99 (-1.29%)
NVDA   787.22 (-7.03%)
AMD   147.62 (-4.81%)
NIO   3.83 (-4.25%)
BABA   68.99 (+0.16%)
T   16.47 (+0.86%)
F   12.11 (+0.41%)
MU   107.10 (-4.32%)
GE   148.90 (-2.64%)
CGC   8.05 (+2.81%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.12 (+0.03%)
XOM   120.00 (+1.25%)
Free Trial
OTCMKTS:CZMWY

Carl Zeiss Meditec (CZMWY) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free CZMWY Stock Alerts
$103.31
+0.11 (+0.11%)
(As of 04/18/2024 ET)
Compare
Today's Range
$102.48
▼
$104.01
50-Day Range
$103.20
▼
$132.38
52-Week Range
$77.44
▼
$138.40
Volume
644 shs
Average Volume
883 shs
Market Capitalization
N/A
P/E Ratio
112.29
Dividend Yield
0.29%
Price Target
N/A
Stock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest
CZMWY stock logo

About Carl Zeiss Meditec Stock (OTCMKTS:CZMWY)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

CZMWY Stock Price History

CZMWY Stock News Headlines

March 25, 2024 | finance.yahoo.com
Carl Zeiss Meditec's (ETR:AFX) investors will be pleased with their respectable 63% return over the last five years
March 21, 2024 | msn.com
Carl Zeiss Meditec AG goes ex dividend tomorrow
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
February 29, 2024 | finance.yahoo.com
Institutions own 23% of Carl Zeiss Meditec AG (ETR:AFX) shares but private companies control 59% of the company
February 13, 2024 | finance.yahoo.com
Carl Zeiss Meditec AG (CZMWY)
January 26, 2024 | seekingalpha.com
Carl Zeiss: We've Seen Outperformance, But I See More Upside Potential
January 11, 2024 | finanznachrichten.de
Carl Zeiss Meditec AG: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
December 19, 2023 | msn.com
Carl Zeiss Meditec to acquire Dutch Ophthalmic for around $1.08B
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
December 18, 2023 | finance.yahoo.com
Carl Zeiss Meditec Full Year 2023 Earnings: EPS Beats Expectations
December 15, 2023 | markets.businessinsider.com
EQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
December 15, 2023 | markets.businessinsider.com
EQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
December 15, 2023 | finance.yahoo.com
Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
December 15, 2023 | finance.yahoo.com
Zeiss Meditec buys Dutch firm for nearly 1 bln euros
November 27, 2023 | finance.yahoo.com
Are Strong Financial Prospects The Force That Is Driving The Momentum In Carl Zeiss Meditec AG's ETR:AFX) Stock?
November 13, 2023 | finance.yahoo.com
Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €84.52?
October 24, 2023 | msn.com
Carl Zeiss Meditec: Premiums Are Proven To Be Dicey In This Market
September 23, 2023 | fool.com
Carl Zeiss Meditec Ag (ETR: AFX)
September 5, 2023 | finance.yahoo.com
Estimating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
August 8, 2023 | msn.com
Carl Zeiss Meditec: One Of The Highest Premiums I'll Accept
July 28, 2023 | seekingalpha.com
CZMWF Carl Zeiss Meditec AG
July 4, 2023 | finance.yahoo.com
There's Been No Shortage Of Growth Recently For Carl Zeiss Meditec's (ETR:AFX) Returns On Capital
June 16, 2023 | fool.com
Carl Zeiss Meditec Ag (OTC: CZMWF)
June 6, 2023 | finance.yahoo.com
Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?
April 12, 2023 | finance.yahoo.com
Institutions own 22% of Carl Zeiss Meditec AG (ETR:AFX) shares but private companies control 59% of the company
February 19, 2023 | finance.yahoo.com
Carl Zeiss Meditec First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
February 3, 2023 | markets.businessinsider.com
EQS-AFR: Carl Zeiss Meditec AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
See More Headlines
Receive CZMWY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/9 Dividend
3/21/2024
Ex-Dividend for 4/10 Dividend
3/22/2024
Dividend Payable
4/09/2024
Dividend Payable
4/10/2024
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:CZMWY
CUSIP
N/A
CIK
N/A
Web
www.zeiss.com
Phone
493641220115
Fax
N/A
Employees
4,823
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
112.29
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover
The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Markus Weber
    CEO & Chairman of Management Board
  • Mr. Justus Felix Wehmer (Age 59)
    CFO & Member of the Management Board
    Comp: $650.23k
  • Dr. Christian Munster (Age 53)
    Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board
  • Stefanie Spanagel
    Chief Operating Officer
  • Mr. Sebastian Frericks
    Director of Investor Relations
  • Eva-Maria Heine
    Chief Human Resources Officer
  • Mr. Steven C. Schallhorn M.D.
    Chief Medical Officer for Global Ophthalmic Devices
  • Mr. Andrew Chang
    Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.
  • Dr. Euan S. Thomson Ph.D. (Age 61)
    President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit
  • Mr. Magnus Reibenspiess
    Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology

Key Competitors

View All Competitors

CZMWY Stock Analysis - Frequently Asked Questions

Should I buy or sell Carl Zeiss Meditec stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CZMWY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CZMWY, but not buy additional shares or sell existing shares.
View CZMWY analyst ratings or view top-rated stocks.

How have CZMWY shares performed in 2024?

Carl Zeiss Meditec's stock was trading at $109.1439 at the start of the year. Since then, CZMWY shares have decreased by 5.3% and is now trading at $103.31.
View the best growth stocks for 2024 here.

Are investors shorting Carl Zeiss Meditec?

Carl Zeiss Meditec saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 400 shares, an increase of 100.0% from the March 15th total of 200 shares. Based on an average daily trading volume, of 900 shares, the short-interest ratio is presently 0.4 days.
View Carl Zeiss Meditec's Short Interest.

How often does Carl Zeiss Meditec pay dividends? What is the dividend yield for Carl Zeiss Meditec?

Carl Zeiss Meditec announced a dividend on Tuesday, February 27th. Investors of record on Monday, March 25th will be given a dividend of $0.8282 per share on Wednesday, April 10th. The ex-dividend date of this dividend is Friday, March 22nd.
Read our dividend analysis for CZMWY.

Is Carl Zeiss Meditec a good dividend stock?

Carl Zeiss Meditec (OTCMKTS:CZMWY) pays an annual dividend of $0.30 per share and currently has a dividend yield of 1.36%. The dividend payout ratio is 32.64%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CZMWY.

How do I buy shares of Carl Zeiss Meditec?

Shares of CZMWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CZMWY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
The “Perfect Storm” for Gold
Gold Safe Exchange
Strange new buyer driving up gold
Stansberry Research
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Your Money is Not Safe
American Alternative
SHOCKING Crypto Leak…
Crypto 101 Media
Top 5 AI Stocks to Buy for 2024
Market Moving Trends